Home
IXHL
IXHL News

Latest Incannex Healthcare Inc. (IXHL) News on July 1, 2025

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

GlobeNewswire

7 days ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

GlobeNewswire

13 days ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

GlobeNewswire

14 days ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

GlobeNewswire

19 days ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

GlobeNewswire

a month ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

GlobeNewswire

a month ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

GlobeNewswire

a month ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

GlobeNewswire

a month ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

GlobeNewswire

a month ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

GlobeNewswire

2 months ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

GlobeNewswire

2 months ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

GlobeNewswire

3 months ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

GlobeNewswire

4 months ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Newsfile

4 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

GlobeNewswire

5 months ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

GlobeNewswire

5 months ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

GlobeNewswire

5 months ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Newsfile

7 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

GlobeNewswire

8 months ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

GlobeNewswire

8 months ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks

Simply Wall St.

8 months ago

Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Newsfile

9 months ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

GlobeNewswire

9 months ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors

GlobeNewswire

10 months ago

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Newsfile

10 months ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

GlobeNewswire

a year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

GlobeNewswire

a year ago

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

GlobeNewswire

a year ago

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

GlobeNewswire

a year ago

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Newsfile

a year ago

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Incannex Healthcare Inc. Quarterly Update, Q1 2024

GlobeNewswire

a year ago

Incannex Healthcare Inc. Quarterly Update, Q1 2024

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

GlobeNewswire

a year ago

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

GlobeNewswire

a year ago

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Clarion Clinics Open for Psychedelic-Assisted Treatments

GlobeNewswire

a year ago

Clarion Clinics Open for Psychedelic-Assisted Treatments

Vuzix Establishes Ophthalmic Advisory Board to Better Serve Human Vision Correction Needs with AR Glasses

PR Newswire

a year ago

Vuzix Establishes Ophthalmic Advisory Board to Better Serve Human Vision Correction Needs with AR Glasses

Sound Financial Bancorp, Inc. Announces Adoption of New Stock Repurchase Program

GlobeNewswire

a year ago

Sound Financial Bancorp, Inc. Announces Adoption of New Stock Repurchase Program

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

GuruFocus.com

a year ago

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

GlobeNewswire

a year ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version

PR Newswire

a year ago

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version

Business Wire

a year ago

Vertex Energy Provides Operational Update for Fourth Quarter 2023

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug

Zacks

a year ago

Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

GlobeNewswire

a year ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

A Look At The Fair Value Of CSP Inc. (NASDAQ:CSPI)

Simply Wall St.

a year ago

A Look At The Fair Value Of CSP Inc. (NASDAQ:CSPI)

Red Robin (RRGB) Gains As Market Dips: What You Should Know

Zacks

a year ago

Red Robin (RRGB) Gains As Market Dips: What You Should Know

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Bright Health Group Adopts NeueHealth as Corporate Brand Name

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

GlobeNewswire

a year ago

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Business Wire

a year ago

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Motley Fool

a year ago

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Zacks

a year ago

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

4 Best Breakout Stocks to Buy for Stellar Returns

Zacks

a year ago

4 Best Breakout Stocks to Buy for Stellar Returns

MainStay MacKay DefinedTerm Municipal Opportunities Fund's Dividend Analysis

GuruFocus.com

a year ago

MainStay MacKay DefinedTerm Municipal Opportunities Fund's Dividend Analysis

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024

GlobeNewswire

a year ago

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024

Is Lakeland Industries (LAKE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

a year ago

Is Lakeland Industries (LAKE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Red Robin (RRGB) Exceeds Market Returns: Some Facts to Consider

Zacks

a year ago

Red Robin (RRGB) Exceeds Market Returns: Some Facts to Consider

RED ROBIN UNLEASHES FAMOUS GOURMET BURGERS, BREWS AND FUN AT NEWEST LOCATION IN ROSSFORD, OHIO

PR Newswire

a year ago

RED ROBIN UNLEASHES FAMOUS GOURMET BURGERS, BREWS AND FUN AT NEWEST LOCATION IN ROSSFORD, OHIO

Digital Initiatives to Aid Red Robin (RRGB) Amid High Costs

Zacks

a year ago

Digital Initiatives to Aid Red Robin (RRGB) Amid High Costs

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

GlobeNewswire

a year ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

Business Wire

a year ago

Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

Vertex Energy Amends Existing Term Loan Agreement

Business Wire

a year ago

Vertex Energy Amends Existing Term Loan Agreement

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06

Simply Wall St.

2 years ago

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

Business Wire

2 years ago

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

Pathfinder Bancorp, Inc. Declares Dividend

GlobeNewswire

2 years ago

Pathfinder Bancorp, Inc. Declares Dividend

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Simply Wall St.

2 years ago

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Pathfinder Bancorp (NASDAQ:PBHC) shareholders have endured a 23% loss from investing in the stock a year ago

Simply Wall St.

2 years ago

Pathfinder Bancorp (NASDAQ:PBHC) shareholders have endured a 23% loss from investing in the stock a year ago

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

Zacks

2 years ago

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

GlobeNewswire

2 years ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Xiao-I’s Smart Speaker Spreads Heartfelt Warmth at the Shanghai New Era Civilization Practice Volunteer Service Season

ACCESSWIRE

2 years ago

Xiao-I’s Smart Speaker Spreads Heartfelt Warmth at the Shanghai New Era Civilization Practice Volunteer Service Season

Some Confidence Is Lacking In CSP Inc. (NASDAQ:CSPI) As Shares Slide 30%

Simply Wall St.

2 years ago

Some Confidence Is Lacking In CSP Inc. (NASDAQ:CSPI) As Shares Slide 30%

Are Investors Undervaluing Rocky Brands (RCKY) Right Now?

Zacks

2 years ago

Are Investors Undervaluing Rocky Brands (RCKY) Right Now?

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

Simply Wall St.

2 years ago

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

KNOT Offshore Partners LP Earnings Release—Interim Results for the Period Ended September 30, 2023

Business Wire

2 years ago

KNOT Offshore Partners LP Earnings Release—Interim Results for the Period Ended September 30, 2023

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

GlobeNewswire

2 years ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Lifecore Biomedical Provides Business Update

GlobeNewswire

2 years ago

Lifecore Biomedical Provides Business Update

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

GlobeNewswire

2 years ago

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

GlobeNewswire

2 years ago

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

Business Wire

2 years ago

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

Associated Press Finance

2 years ago

Dynagas: Q3 Earnings Snapshot

Dynagas LNG Partners LP Reports Results For the Three and Nine Months Ended September 30, 2023

GlobeNewswire

2 years ago

Dynagas LNG Partners LP Reports Results For the Three and Nine Months Ended September 30, 2023

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

GlobeNewswire

2 years ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE

GlobeNewswire

2 years ago

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE

Business Wire

2 years ago

Western Asset Mortgage Capital Corporation Announces Stockholder Approval of Merger With AG Mortgage Investment Trust

System1 to Report Third Quarter 2023 Financial Results

Business Wire

2 years ago

System1 to Report Third Quarter 2023 Financial Results

Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023

GlobeNewswire

2 years ago

Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023

Within 72 Hours, 10,000 Pledge to Become Conscious Travelers

PR Newswire

2 years ago

Within 72 Hours, 10,000 Pledge to Become Conscious Travelers

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

GlobeNewswire

2 years ago

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Citi Trends Inc Earnings Call

Why Citi Trends Stock Trended Down Today

Motley Fool

2 years ago

Why Citi Trends Stock Trended Down Today

Citi Trends (CTRN) Q3 2023 Earnings Call Transcript

Motley Fool

2 years ago

Citi Trends (CTRN) Q3 2023 Earnings Call Transcript

Loop Industries to Participate in Upcoming Investor Conferences in November and December 2023

ACCESSWIRE

2 years ago

Loop Industries to Participate in Upcoming Investor Conferences in November and December 2023

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire

2 years ago

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Is OFS Capital (OFS) a Great Stock for Value Investors?

Zacks

2 years ago

Is OFS Capital (OFS) a Great Stock for Value Investors?

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross

Zacks

2 years ago

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross

AG Mortgage Investment Trust, Inc. Announces Second Interim Fourth Quarter Common Dividend of $0.05 Per Share

Business Wire

2 years ago

AG Mortgage Investment Trust, Inc. Announces Second Interim Fourth Quarter Common Dividend of $0.05 Per Share

Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC

GlobeNewswire

2 years ago

Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC

Institutions profited after Gossamer Bio, Inc.'s (NASDAQ:GOSS) market cap rose US$59m last week but individual investors profited the most

Simply Wall St.

2 years ago

Institutions profited after Gossamer Bio, Inc.'s (NASDAQ:GOSS) market cap rose US$59m last week but individual investors profited the most

Analysts Expect Breakeven For CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Before Long

Simply Wall St.

2 years ago

Analysts Expect Breakeven For CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Before Long

Loop Industries Presents Its Infinite Loop(TM) Technology at Groundbreaking Ceremony of the Ulsan Advanced Recycling Cluster in South Korea

ACCESSWIRE

2 years ago

Loop Industries Presents Its Infinite Loop(TM) Technology at Groundbreaking Ceremony of the Ulsan Advanced Recycling Cluster in South Korea

Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca

GlobeNewswire

2 years ago

Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca

Share on Social Networks: